Vijay Kedia Portfolio: 10 stocks surge up to 44% in CY26, 5 new picks added
TLDR
- โ10 stocks in Vijay Kedia's portfolio surged up to 44% in CY26
- โ13 holdings posted positive returns while others declined; five new picks added
- โPortfolio positioning signals fresh conviction bets in India small/mid-cap growth sectors
Why this matters
Coverage sentiment: Bullish (1 bullish ยท 0 neutral ยท 0 bearish)
Vijay Kedia is a closely-watched Indian retail investing icon; his portfolio moves are a proxy sentiment indicator for India's small/mid-cap segment and often trigger copycat buying among domestic retail investors.
What to watch
- โข Q1 FY27 (June 2026 quarter) shareholding disclosures โ monitor if Kedia adds to or exits the five new March 2026 picks
- โข ACE Equity & Trendlyne data updates post-June 2026 quarter close for full portfolio valuation changes
Ripple effects
- โข Indian small/mid-cap stocks โ bullish pressure as retail investors track and replicate Kedia's new picks
AI-Synthesized news from multiple sources
This article was synthesized by AI from the source articles listed below, reviewed by a second-pass AI quality reviewer, and published by the market.news editorial system. How we do this ยท Editorial standards ยท Report an error
The Quick Take
- 10 stocks in Vijay Kedia's portfolio gained between 10% and 44% in CY26 price performance
- Portfolio delivered mixed results: 13 stocks posted positive returns while remaining holdings registered losses
- Five new stock additions were made during the March 2026 quarter, signalling fresh conviction bets
- Watch for further portfolio reshuffling in upcoming quarters as Kedia positions in new sectors
- Kedia's India small/mid-cap focus reflects broader emerging-market appetite for domestic-growth stories
Synthesized from 1 source โ full coverage, sentiment breakdown, and forward signals below.
Related coverage:
Market Intelligence Panel
Sentiment
BullishCoverage
livesource covering this story
Live Price
NSE:NIFTY๐ Key Numbers
๐ India / Asia Angle
Vijay Kedia is a closely-watched Indian retail investing icon; his portfolio moves are a proxy sentiment indicator for India's small/mid-cap segment and often trigger copycat buying among domestic retail investors.
๐ Ripple Effects
- โธIndian small/mid-cap stocks โ bullish pressure as retail investors track and replicate Kedia's new picks
- โธIndian equity mutual funds & SIPs โ positive sentiment spills into domestic equity inflows as marquee portfolios outperform
- โธEmerging-market ETFs โ outperformance of high-conviction India portfolios reinforces FII interest in Indian equities
๐ญ What to Watch Next
PRO- โธQ1 FY27 (June 2026 quarter) shareholding disclosures โ monitor if Kedia adds to or exits the five new March 2026 picks
- โธACE Equity & Trendlyne data updates post-June 2026 quarter close for full portfolio valuation changes
- โธBSE/NSE small-cap and mid-cap index performance โ a sustained rally would validate Kedia's bullish positioning
Market news synthesis. Not financial advice. Sources cited above.
How the Story Spread
1 publisher covering this story
AI synthesis of every source listed below. Tier 1 = wire services (AP, Reuters via wire, Bloomberg, official central banks). Tier 2 = major financial publishers. Tier 3 = niche / specialist outlets. Click any card to read the original article.
Get the Daily Briefing
Pre-market analysis every morning at 6am ET. Free.
Was this article useful?
Anonymous ยท helps us tune the editorial system
More ๐ฎ๐ณ India Stories
India Bonds Rally as Dovish RBI Hold and Oil Price Decline Send Yields Below Key Levels
India government bond yields fell below key levels as RBI held rates with a dovish tone and crude oil prices dropped; OIS rates signal earlier rate cuts now priced in.
Aug 6, 2026
๐ฎ๐ณ IndiaNeuland Laboratories Q1 FY27 Profit Jumps Over 10-Fold to โน148 Crore as Pharma CDMO Business Scales
Neuland Laboratories Q1 profit surged over 10x to โน148 crore as CMS and GDS segments both grew; India's pharma CDMO sector benefits from global supply chain diversification away from China.
Aug 6, 2026
๐ฎ๐ณ IndiaNavin Fluorine Q1 FY27 Profit More Than Doubles to โน243 Crore as Specialty Chemicals Earnings Inflect
Navin Fluorine Q1 profit more than doubled to โน243 crore on revenue growth and margin expansion; โน90 crore advanced materials investment approved amid India specialty chemicals recovery.
Aug 6, 2026